# Advaccine: Research, Su Zhou Shi, China

> Advaccine: Advaccine is an innovative vaccine company with a high-value prophylactic and therapeutic vaccine pipeline driven by in-house developed...

Source: https://millionrounds.com/startup/advaccine (Millionrounds; every figure on the page links to its filing or article)

China · [Research startup](https://millionrounds.com/companies)

# Advaccine

Advaccine is an innovative vaccine company with a high-value prophylactic and therapeutic vaccine pipeline driven by in-house developed technology platforms and industrial manufacturing capabilities.

Funding reported Last round: Venture (Round not Specified)

Research Su Zhou Shi, China

Company summary

- **Founded:** 2009 17 years old
- **Team:** 6 1 to 10 people
- **Funding reported:** 38.2M as listed, currency not stated
- **Last round:** Venture (Round not Specified) Apr 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Advaccine has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Advaccine

Advaccine is an innovative vaccine company with a high-value prophylactic and therapeutic vaccine pipeline driven by in-house developed technology platforms and industrial manufacturing capabilities.

Its pipeline consists of potential first-in-class key assets developed to address diseases caused by SARS-CoV-2, respiratory syncytial virus (RSV) and hepatitis B virus (HBV), which are diseases with huge unmet medical needs. Advaccine is also developing a series of cancer vaccine candidates, covering viral-related oncology, neoantigen-based therapeutic vaccines and tumor-associated antigen therapeutic vaccines.

## What company datasets say Advaccine raised

Funding, as reported

Reported in all **38.2M** in the source's currency

Last round **Venture (Round not Specified)**

Last round size **6.6M**

Last round date **Apr 2021**

## The company, in detail

What they build

Known for

biotechnology research and

Built with from their website

Microsoft 365 Alibaba Cloud

- **Sector:** Research
- **Region:** Jiang Su Sheng

## Research in China

Startups like it

- [**CMAB Biopharma** Suzhou · founded 2017 *Raised*](https://millionrounds.com/company/cmab-biopharma)
- [**HaploX Biotechnology** Shenzhen Shi · founded 2014 *Raised*](https://millionrounds.com/company/haplox-biotechnology)
- [**TriArm Therapeutics** founded 2018 *Raised*](https://millionrounds.com/company/triarm-therapeutics)
- [**Cure Genetics** Suzhou · founded 2016 *Raised*](https://millionrounds.com/company/curegenetics)
- [**BGI Group** Shenzhen Shi · founded 1999](https://millionrounds.com/startup/bgi-group)
- [**Baiming Xinkang Biotechnology (Hangzhou) Co., Ltd. Worgpharma)** Hang Zhou Shi · founded 2018](https://millionrounds.com/startup/baiming-xinkang-biotechnology-hangzhou-co-ltd-worgpharma)
- [**Abogen Biosciences** Wuxi · founded 2019](https://millionrounds.com/startup/abogen-biosciences)
- [**Chengdu Qitan Technology Co., Ltd.** Beijing · founded 2016](https://millionrounds.com/startup/chengdu-qitan-technology-co-ltd)

## Is this your company?

Add your raise, your deck and your story, and put Advaccine in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)